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At a synapse, the presynaptic active zone mediates
synaptic vesicle exocytosis. RIM proteins are active
zone scaffolding molecules that—among others—
mediate vesicle priming and directly or indirectly
interact with most other essential presynaptic
proteins. In particular, the Zn2+ finger domain of
RIMs binds to the C2A domain of the priming factor
Munc13, which forms a homodimer in the absence
of RIM but a heterodimer with it. Here, we show
that RIMs mediate vesicle priming not by coupling
Munc13 to other active zone proteins as thought
but by directly activating Munc13. Specifically, we
found that the isolated Zn2+ finger domain of RIMs
autonomously promoted vesicle priming by binding
to Munc13, thereby relievingMunc13 homodimeriza-
tion. Strikingly, constitutively monomeric mutants of
Munc13 rescued priming in RIM-deficient synapses,
whereas wild-type Munc13 did not. Both mutant and
wild-type Munc13, however, rescued priming in
Munc13-deficient synapses. Thus, homodimeriza-
tion of Munc13 inhibits its priming function, and
RIMs activate priming by disrupting Munc13 homo-
dimerization.
INTRODUCTION
Neurotransmission is initiated when synaptic vesicles undergo
exocytosis at the active zone, thereby releasing their neurotrans-
mitter contents (Katz, 1969). Synaptic vesicle exocytosis is
highly regulated, consistent with its role as the gatekeeper of
neurotransmission (Stevens, 2003). Each event of exocytosis is
induced by an action potential that induces Ca2+ influx via
Ca2+ channels located in or near the active zone. The efficacy
of action-potential-induced exocytosis depends on at least three
parameters: the local activity of voltage-gated Ca2+ channels,
the number of release-ready vesicles, and the Ca2+ sensitivity
of these vesicles. Remarkably, none of the proteins that mediate
these parameters (i.e., Ca2+ channels, the presynaptic fusion
machinery composed of SNARE and SM proteins, and theCa2+ sensor synaptotagmin) is exclusively localized to the active
zone. Instead, their functions are organized at presynaptic
release sites by the protein components of active zones (Su¨dhof,
2004; Wojcik and Brose, 2007).
Among active zone protein components, RIM proteins are
arguably the most central elements (Mittelstaedt et al., 2010).
RIMs directly or indirectly interact with all other active zone
proteins (Wang et al., 2000, 2002; Betz et al., 2001; Schoch
et al., 2002; Ohtsuka et al., 2002; Ko et al., 2003), Ca2+ channels
(Hibino et al., 2002; Kiyonaka et al., 2007; Kaeser et al., 2011),
and the synaptic vesicle proteins Rab3 and synaptotagmin-1
(Wang et al., 1997; Coppola et al., 2001; Schoch et al., 2002).
Consistent with a central role for RIMs in active zones, RIM
proteins are essential for presynaptic vesicle docking, priming,
Ca2+ channel localization, and plasticity (Koushika et al., 2001;
Schoch et al., 2002, 2006; Castillo et al., 2002; Calakos et al.,
2004; Weimer et al., 2006; Gracheva et al., 2008; Kaeser et al.,
2008, 2011; Fourcaudot et al., 2008; Han et al., 2011). However,
apart from recent progress in understanding the role of RIMs in
vesicle docking and in localizing Ca2+ channels to active zones
(Gracheva et al., 2008; Schoch et al., 2006; Kaeser et al., 2008,
2011; Han et al., 2011), it remains unclear how RIMs perform
their functions. This gap in our understanding arose in part
because multiple RIM isoforms are coexpressed in vertebrates,
creating redundancy (Wang and Su¨dhof, 2003), and because
presynaptic rescue experiments require expression of rescue
proteins in all neurons that are being analyzed, which is techni-
cally difficult for large proteins like RIMs.
One of the best documented phenotypes in RIM-deficient
neurons is a strong reduction in vesicle priming (Koushika
et al., 2001; Schoch et al., 2002; Calakos et al., 2004; Kaeser
et al., 2008, 2011; Han et al., 2011). Priming activates synaptic
vesicles for exocytosis, thereby creating the readily releasable
pool (RRP) of vesicles. However, the nature of priming in general,
and of the role of RIMs in priming in particular, remains unknown;
even the relation of priming to docking—the process that phys-
ically attaches vesicles to the active zone as analyzed by elec-
tron microscopy—is unclear. In pioneering work, Rosenmund
and Stevens (1996) showed that vesicles in the RRP can be
induced to undergo exocytosis by application of hypertonic
sucrose, which triggers vesicle fusion by a Ca2+-independent,
nanomechanical mechanism. Although the nonphysiological
nature of the sucrose stimulus limits its usefulness (e.g.,
see Wu and Borst, 1999; Moulder and Mennerick, 2005),Neuron 69, 317–331, January 27, 2011 ª2011 Elsevier Inc. 317
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Mechanism of vesicle priming by RIMmeasurements of vesicle pool sizes using this stimulus have
been successfully applied as an operational definition of the
RRP in many studies (e.g., see Basu et al., 2005; Betz et al.,
2001; Rosenmund et al., 2002). Here, we also employ this
approach, with the understanding that the operational definition
of the RRP as the sucrose-stimulated vesicle pool includes both
docking and priming since the two processes cannot be sepa-
rated (Xu-Friedman et al., 2001).
The synaptic vesicle membrane fusion machinery is
composed of SNARE and SM proteins and constitutes a central
element of priming; in addition, multiple other priming proteins
have been characterized. Among these, the most important
besides RIMs are likely Munc13s, which are multidomain
proteins of active zones that are essential for all synaptic vesicle
priming and additionally participate in shaping short-term
synaptic plasticity (Brose et al., 1995; Augustin et al., 1999a;
Rosenmund et al., 2002). Munc13s most likely function by inter-
acting with SNARE proteins (Betz et al., 1997; Basu et al., 2005;
Madison et al., 2005; Stevens et al., 2005; Guan et al., 2008);
interestingly, they also directly bind to RIMs (Betz et al., 2001;
Schoch et al., 2002; Dulubova et al., 2005). Most RIM isoforms
contain an N-terminal Zn2+ finger domain that binds to the
N-terminal C2A domain of the Munc13 isoforms Munc13-1 and
ubMunc13-2. Importantly, the Munc13 C2A domain (which
does not bind Ca2+, different from synaptotagmin C2 domains
but similar to RIM C2 domains) forms a tight homodimer in the
absence of the RIM Zn2+ finger; binding of the RIM Zn2+ finger
to the Munc13 C2A domain converts this homodimer into
a RIM/Munc13 heterodimer (Dulubova et al., 2005; Lu et al.,
2006). Furthermore, the Zn2+ finger domain of RIMs is flanked
by a-helical sequences that bind to Rab3 (Wang et al., 1997).
Thus, the N-terminal sequence of RIMs can mediate simulta-
neous binding of RIMs to Munc13 as a priming factor and to
Rab3 as a vesicle GTP-binding protein (Dulubova et al., 2005).
Together, the structural and genetic data on the Munc13/RIM/
Rab3 complex prompted the hypothesis that RIMs activate
synaptic vesicle priming by recruiting Munc13 to the active
zone and stabilizing it there and that the crucial function of
RIMs is to colocalize Munc13 with synaptic vesicles via their
N-terminal sequences and with other active zone proteins and
Ca2+ channels via their C-terminal sequences (Wang et al.,
1997, 2000, 2002; Betz et al., 2001; Schoch et al., 2002; Ohtsuka
et al., 2002; Ko et al., 2003; Andrews-Zwilling et al., 2006; Kaeser
et al., 2008, 2011). In the present paper, we have tested this
hypothesis using rescue experiments with newly generated
conditional double-knockout (DKO) mice targeting all major
presynaptic RIM isoforms (Kaeser et al., 2011). Unexpectedly,
we find that RIMs do not act during vesicle priming as classical
scaffolding proteins, i.e., that their mechanism of action does
not require the close colocalization of target proteins. Instead,
we show that the isolated RIM Zn2+ finger domain is sufficient
for activating priming, and that it functions by binding to
Munc13, thereby disrupting Munc13 homodimers. Specifically,
we show that mutant, constitutively monomeric forms of
Munc13 can reverse the priming deficiency in RIM-deficient
synapses, whereas wild-type Munc13 cannot, but strikingly
both mutant monomeric and wild-type Munc13 rescue priming
in Munc13-deficient synapses. Thus, RIMs switch on Munc13’s318 Neuron 69, 317–331, January 27, 2011 ª2011 Elsevier Inc.priming function by disrupting the autoinhibitory homodimeriza-
tion of Munc13.
RESULTS
RIM Deletion Reduces the Priming Capacity
of Active Zones
We recently generated conditional DKO mice in which cre-
recombinase deletes expression of all multidomain presynaptic
RIM isoforms (i.e., RIM1a, 1b, 2a, 2b, and 2g; Kaeser et al.,
2011). To explore how RIMs function in synaptic vesicle priming,
we cultured hippocampal neurons from conditional RIM DKO
mice and infected them either with a lentivirus expressing
inactive mutant (control) or active wild-type EGFP-tagged cre-
recombinase (referred to as cDKO neurons). Measurements of
spontaneous excitatory and inhibitory ‘‘mini’’ synaptic events
(mEPSCs and mIPSCs, respectively) showed that the frequency
ofmEPSCs andmIPSCswas decreasedmore than 10- andmore
than 3-fold, respectively, in RIM-deficient neurons, whereas
their amplitudes were unchanged (Figures 1A and 1B). This
finding supports previous data that RIMs are essential for
a normal presynaptic release probability in excitatory and inhib-
itory synapses (Schoch et al., 2002, 2006; Calakos et al., 2004;
Kaeser et al., 2008, 2011; Han et al., 2011; see also Figure S1,
available online). Thus, in the following, we analyzed only inhibi-
tory synaptic transmission that does not exhibit network activity
and is easier to evaluate in cultured neurons (Maximov et al.,
2007).
Assessments of the RRP in RIM-deficient cDKO neurons with
a 30 s application of hypertonic sucrose uncovered a more than
4-fold decrease in the RRP size (Figure 1C). Hypertonic sucrose
induces an initial release transient that corresponds to the RRP
and then transitions into a steady-state phase that corresponds
to the continuous stimulation of the exocytosis of vesicles refill-
ing the RRP (Rosenmund and Stevens, 1996). Comparison of
release triggered during the initial transient (i.e., the first 10 s of
sucrose application) or during the steady-state phase (i.e., the
last 15 s of the application) revealed that the RIM deletion sup-
pressed both phases equally (Figure 1C). Plots of the cumulative
charge transfer showed that the kinetics of sucrose-induced
release were unchanged (Figure 1D). These findings indicate
that the RIM deletion decreased the total capacity of the RRP
but not its steady-state refilling rate.
Measurements of the levels of active zoneproteins andof other
essential presynaptic proteins in RIM-deficient neurons uncov-
ered only a single major change: a decrease in Munc13-1 levels
in the cDKO neurons lacking all presynaptic RIM isoforms (Fig-
ure 1E), with the decrease in Munc13-1 levels observed here
being slightly larger (67%) than that observed previously in brains
frommice lacking only RIM1a (60%)(Schoch et al., 2002). Thus,
deletion of RIMsdoes not produce a global change in the compo-
sition of the release machinery but a discrete change in one
particular interacting protein, Munc13.
We next characterized the dynamics of the RRP in RIM-defi-
cient synapses. Measurements of the refilling of the RRP after
sucrose-induced depletion, with a second sucrose stimulus
applied at variable interstimulus intervals, showed that although
the RRP in RIM-deficient synapses is massively reduced, its
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Figure 1. Conditional Deletion of RIM1a, 1b, 2a, 2b,
and 2g Dramatically Decreases the RRP Size
All experiments in this and most of the following figures
employ hippocampal neurons cultured from conditional
RIM1/2 DKO mice that were infected with lentiviruses
expressing inactive (Control) or active cre-recombinase
(cDKO).
(A and B) Sample traces (left) and summary graphs (right)
of the frequency and amplitude of spontaneous miniature
excitatory (mEPSCs) and inhibitory postsynaptic currents
(mIPSCs), monitored in control (gray) and RIM-deficient
cDKO hippocampal neurons (black).
(C) Sample traces (left) and summary graphs (right, as
charge transfer) of inhibitory postsynaptic currents
induced by hypertonic sucrose (0.5 M) in control (gray)
and RIM-deficient cDKO (black) neurons. Hypertonic
sucrose was puffed onto the patched neuron for 30 s in
the presence of 1 mM TTX, 10 mM CNQX, and 50 mM
APV. Charge transfer during the initial (0–10 s) and the
steady-state responses (15–30 s of application) were
quantified to estimate the RRP size and the RRP recovery
rate, respectively.
(D) Cumulative charge transfer (left) and kinetic analyses of
the cumulative charge transfer (right) of sucrose-induced
postsynaptic currents in control (gray) and RIM-deficient
cDKO neurons (black). The integrated charge transfer
was fitted by a double-exponential function to determine
kinetic parameters for the fast and the slow component
(tfast, Afast and tslow, Aslow, respectively).
(E) Sample immunoblots (left) and protein quantitations
(right) of control and cDKO neurons.
Data shown are means ± SEMs (numbers in bars indicated
numbers of cells and cultures analyzed). Statistical
significance was assessed by Student’s t test (*p < 0.05;
***p < 0.001). For short-term synaptic plasticity, see
Figure S1.
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Figure 2. Differential Effects of the RIM
Deletion on RRP Capacity and Refilling
Rates
(A) Representative IPSC traces (left) and summary
graphs (right, showing absolute and normalized
data) of the RRP recovery as a function of the inter-
puff interval between two sucrose applications,
applied at increasing interstimulus intervals (10,
20, 60, and 120 s). RRP recovery was calculated
by dividing the second sucrose-induced charge
transfer by the first; in the right graph, the resulting
ratio was normalized to that observed at the 120 s
interval.
(B) Sample traces (left) and summary data (right,
showing absolute and normalized data) of the
recovery rate of single evoked IPSCs after
sucrose-induced RRP depletion. IPSC amplitudes
were measured at multiple time points after RRP
depletion (10, 30, 60, 120 s), and normalized to
control IPSC amplitudes before RRP depletion.
(C) Sample traces (top) and summary graph of the
IPSC amplitudes (bottom) measured in cDKO and
control neurons during depletion of the RRP by a
50 Hz stimulus train applied for 1 s and during
the recovery from the RRP depletion after the train.
The stimulation protocol is outlined on top;
neurons were stimulated with ten pulses at
0.2 Hz before the high-frequency train. For the
responses in RIM-deficient cDKO neurons, both
absolute and normalized data are shown. For
expanded views of IPSCs during the high-
frequency train and an analysis of the delayed
release kinetics, see Figure S2.
Data shown are means ± SEMs. Statistical signifi-
cance was assessed by 2-way ANOVA (**p < 0.01;
***p < 0.001). p values and numbers are listed in
Table S2.
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Mechanism of vesicle priming by RIMrelative refilling rate is unchanged (Figure 2A). We then used
a more physiological stimulus for monitoring the RRP recovery
after sucrose-induced depletion and applied isolated action
potentials at increasing intervals after RRP depletion (Figure 2B).
Again, RIM-deficient synapses exhibited a normal relative rate of
recovery after sucrose depletion.
Finally, we examined the recovery of synaptic responses after
the RRP had been depleted by a 50 Hz stimulus train applied
for 1 s (Figure 2C). The amount of release triggered during the
stimulus train appeared decreased in RIM-deficient synapses,
consistent with a decrease in the RRP, and no synaptic
responses were detectable at the end of the train in either control
or RIM-deficient synapses (Figure S2A), suggesting that the RRP
was depleted.
During the initial recovery period, control and RIM-deficient
cDKO neurons exhibited an identical absolute recovery rate of
inhibitory postsynaptic currents (IPSCs) and an increased rela-
tive recovery rate. After the initial period, however, the IPSCs in
control neurons continued to increase because their RRP was
not yet refilled, whereas the IPSCs in RIM-deficient neurons320 Neuron 69, 317–331, January 27, 2011 ª2011 Elsevier Inc.exhibited no further increase, presumably because their smaller
RRP was already full after a short recovery period (Figure 2C).
These results suggest that the RRP in RIM-deficient synapses
refills relatively faster after depletion with a stimulus train than
after depletion by hypertonic sucrose, possibly because the
Ca2+-dependent acceleration of vesicle priming is relatively
more effective in the RIM-deficient synapses.
The RIM Zn2+ Finger Acts Autonomously
in Synaptic Vesicle Priming
A plausible hypothesis is that RIM acts in vesicle priming via
Munc13, the dominant priming factor in the presynaptic active
zone (Augustin et al., 1999a; Varoqueaux et al., 2002). RIM
proteins bind to Munc13 via their Zn2+ finger domain (Betz
et al., 2001; Schoch et al., 2002; Dulubova et al., 2005); binding
is mediated by two critical lysine residues in the RIM Zn2+ finger
domain (K144 and K146) whose mutation blocks Munc13
binding (Dulubova et al., 2005; Lu et al., 2006). To ensure that
the Zn2+ finger is the only RIM sequence that binds to Munc13,
we examined the interaction of ubMunc13-2 with wild-type
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Figure 3. RIM N-Terminal Domains Mediate Synaptic Vesicle
Priming
(A) Diagram of full-length wild-type and mutant RIM1a and RIM1b rescue
proteins expressed in RIM-deficient cDKO neurons via an IRES sequence
from the same mRNA as cre-recombinase (asterisk = K144/6E substitution).
(B) Localization of wild-type or K144/6E mutant RIM1a and ubMunc13-2 in
transfected HEK293 cells. RIMs and ubMunc13-2 were transfected either
alone (top) or in combination, and their colocalization was studied after
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Mechanism of vesicle priming by RIMand mutant RIM1a in transfected HEK293 cells by imaging the
Munc13-dependent recruitment of RIM1a to themembrane (Fig-
ure 3B) or by crosslinking studies (Figure 3C). We used a RIM1a
mutant that contains glutamate substitutions in the two lysine
residues of the Zn2+ finger domain that are critical for Munc13
binding (the K144/6E mutation) (Dulubova et al., 2005). Further-
more, we used the ubMunc13-2 isoform of Munc13 because
this isoform was characterized best in previous rescue experi-
ments (e.g., see Rosenmund et al., 2002; Junge et al., 2004;
Shin et al., 2010). Both the imaging and the crosslinking experi-
ments showed that full-length wild-type RIM1a was tightly
bound to ubMunc13-2 via its Zn2+ finger domain, whereas the
Zn2+ finger domain mutants of full-length RIM1a were not, indi-
cating that the only RIM sequence that binds to ubMunc13-2 is
the RIM Zn2+ finger domain (Figures 3B and 3C and Figure S3A).
Note that chemical crosslinking of proteins by glutaraldehyde
is an inherently low-efficiency technique that depends on the
precise distance of reactive groups in a protein complex and
on the concentration of the crosslinking agent. As a result,
the degree of RIM-Munc13 crosslinking observed here does
not reflect the stoichiometry of the RIM/Munc13 complex, and
the crosslinking data are most meaningfully interpreted as
the differences between the wild-type and mutant RIM and
Munc13 proteins, as evidenced by the loss of high-molecular
weight crosslinked proteins with mutant RIM1aK144/6E that
does not bind to Munc13. In contrast to crosslinking results,
colocalization in the imaging results does give a representation
of how much of the RIM and Munc13 proteins are in a true
complex, suggesting that there is stoichiometric binding for the
wild-type but not mutant proteins (Figures 3B and 3C).
We then tested whether Munc13 binding by the RIM Zn2+
finger domain is required for RIM-dependent vesicle priming
by expressing rescue proteins in RIM-deficient neurons.
Wild-type RIM1a and RIM1b reversed the decrease intranslocation of Munc13 by phorbol ester (PMA) to the plasma membrane.
Note that without Munc13 binding, RIM1a is sequestered into the nucleus in
nonneuronal cells but recruited to the plasma membrane in the presence of
ubMunc13-2 and PMA (N is an abbreviation for nucleus. The scale bar repre-
sents 5 mm).
(C) Crosslinking of wild-type or K144/6Emutant RIM1awithMunc13s. HEK293
cells expressing the indicated proteins were treated in control solution or
solution containing 0.008% glutaraldehyde, and proteins were analyzed by
SDS-PAGE and immunoblotting with antibodies against the HA-tag of
RIM1a or against the central domains of RIM (R809). ubMunc13-2 monomer
was detectedwith antibodies against themVenus tag (* indicates an unspecific
band). Note that we included as a control the K32Emutant of ubMunc13-2 that
does not homodimerize but retains RIM binding (see Lu et al., 2006). The high-
molecular weight bands are not clearly resolved on the blot, probably because
of their large size and variable degrees of crosslinking.
(D) Sample traces (left) and summary graphs of the frequency (right) of spon-
taneousmIPSCsmonitored in control andRIM-deficient cDKO neurons with or
without RIM rescue.
(E) Sample traces (left) and summary graphs of the RRP size as measured by
the initial sucrose response (right, top) and of the steady-state refilling size
(right, bottom) in control neurons, and cDKO neurons with or without rescue.
Rescue efficacies are shown in Figure S3 and Table S3.
Data shown are means ± SEMs (numbers in bars indicated numbers of cells
and cultures analyzed). Statistical significance was assessed by one-way
ANOVA (*p < 0.05; **p < 0.01; ***p < 0.001).
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Figure 4. RIM N-Terminal Domains Are Necessary and Sufficient for
Priming
(A) Diagram of full-length RIM1a and of RIM1a fragments expressed as rescue
proteins in RIM-deficient cDKO neurons via an IRES sequence from the same
mRNA as cre-recombinase. The single-letter code above the RIM1a diagram
identifies the various domains (The following abbreviations are used: R, Rab3-
binding a-helical region; Z, Munc13-binding Zn2+ finger region; P, PDZ
domain; A, C2A domain; S, proline-rich SH3-binding PxxP motif; B, C2B
domain); H marks the presence of a human influenza hemagglutinin (HA)-tag.
(B–D) Sample traces (left) and summary graphs of initial and steady-state RRP
sizes in control or RIM-deficient cDKO neurons without or with rescue with
RIM1a (B), RIM-RZ (C), or RIM-PASB (D).
(E) Analysis of IPSCs evoked by a 10 Hz stimulus train in control neurons, RIM-
deficient cDKO neurons without rescue, or RIM-deficient cDKO neurons
rescued with the RIM-RZ or the RIM-PASB fragment. Note that unlike
sucrose-evoked release, action-potential-induced release is partly rescued
by both RIM fragments.
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RIM1a appeared to even enhance spontaneous release (Fig-
ure 3D). The Zn2+ finger domain mutation in RIM1a and RIM1b,
however, impaired rescue. Moreover, RIM1a and RIM1b both
rescued the impairment in sucrose-induced release in RIM-defi-
cient neurons; again, the Zn2+ finger mutation partly blocked this
rescue in RIM1a and completely in RIM1b (Figure 3E and Fig-
ure S3C). Overall, these experiments indicate that in RIM
proteins, the Zn2+ finger domain is the major effector domain
for priming; moreover, the experiments show that RIM1a may
mediate rescue more efficiently than RIM1b, consistent with
the notion that the N-terminal Rab3-binding activity of RIM1a
(which is absent from RIM1b; Kaeser et al., 2008) contributes
to release.
We next asked whether the RIM Zn2+ finger requires the
context of other C-terminal domains of RIM to promote priming,
as would be expected for a scaffolding protein, or whether it acts
autonomously. We examined rescue with RIM1a fragments
composed of either only its N-terminal Rab3- and Munc13-
binding sequences (referred to as the RIM-RZ fragment), or of
its C-terminal fragment containing the PDZ, C2A, and C2B
domains and the RIM-BP-binding sequence (referred to as
the RIM-PASB fragment; Figure 4A). Surprisingly, the N-terminal
RIM-RZ fragment was sufficient to rescue vesicle priming
in RIM-deficient neurons, whereas the C-terminal PASB-
fragment had no rescue effect (Figures 4B–4D; note that the
RIM-PASB fragment efficiently rescues the Ca2+ influx impair-
ment in RIM-deficient neurons [Kaeser et al., 2011]). Importantly,
the N-terminal RIM-RZ fragment did not significantly alter
vesicle priming when overexpressed in wild-type neurons (Fig-
ure S4). Unlike release induced by hypertonic sucrose, both
the N-terminal and the C-terminal RIM1a fragment increased
release stimulated by a 10 Hz train of action potentials (Fig-
ure 4E). This result is consistent with completely separated roles
of the N-terminal RIM domains in vesicle priming and of the
C-terminal RIM domains in boosting local Ca2+ influx (Kaeser
et al., 2011).
The rescue of priming in RIM-deficient neurons by the RIM-RZ
fragment alone is surprising because it suggests that RIM does
not act as a classical scaffolding protein that functions by recruit-
ing multiple other proteins via its N- and C-terminal domains to
the same subcellular location. However, the RIM-RZ fragment
still binds to two proteins in a trimeric complex—Rab3 and
Munc13 (Dulubova et al., 2005). Thus, its rescue activity could
either be mediated by coupling Rab3 on synaptic vesicles to
Munc13 in the active zone or it could be because of autonomous
functions of each of its binding activities.
To distinguish between these two possibilities, we systemati-
cally eliminated Rab3 and Munc13 binding from the RIM-RZ
fragment, the former by using the equivalent fragment from
RIM1b that lacks Rab3 binding (RIM-Z) and the latter by intro-
ducing the Zn2+ finger mutations into the RIM-RZ and RIM-ZData shown are means ± SEMs (numbers in bars indicated numbers of cells
and cultures analyzed). Statistical significance was assessed by one-way
ANOVA (**p < 0.01; ***p < 0.001). For an analysis of the effect of RIM-RZ
expression in wild-type neurons, see Figure S4; numerical values are shown
in Table S4.
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Figure 5. Munc13 Binding by the N-Terminal RIM Zn2+ Finger
Domain Autonomously Activates Vesicle Priming
(A) Diagram of N-terminal wild-type and mutant RIM fragments expressed as
rescue proteins in cDKO neurons via an IRES sequence from the same mRNA
as cre-recombinase (asterisk = K144/6E substitution).
(B) Sample traces (left) and summary graph (right) of the frequency of sponta-
neous mIPSCs monitored either in control neurons and cDKO neurons with or
without rescue.
(C) Sample traces (left) and summary graphs (right) of RRP size in control
neurons and cDKO neurons with or without rescue. Rescue efficacies are
indicated in Figure S5 and Table S5.
Data shown are means ± SEMs (numbers in bars indicated numbers of cells
and cultures analyzed). Statistical significance was assessed by one-way
ANOVA (*p < 0.05; **p < 0.01; ***p < 0.001).
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Mechanism of vesicle priming by RIMfragments (Figure 5A). Rescue experiments with these fragments
showed that both the RIM-RZ and the RIM-Z fragment rescued
40%–60% of the decrease in spontaneous (Figure 5B) and
sucrose-evoked release (Figures 5C and Figure S5), whereas
the Zn2+ finger mutations blocked part of the rescue in RIM-RZ
and all of the rescue in the RIM-Z fragment. Thus, the isolated
Rab3- and Munc13-binding domains of RIMs act as autono-
mous switches to activate priming, and their actions are inde-
pendent of each other and additive, with the RIM Zn2+ finger
domain having a bigger effect on spontaneous release and
RRP size than the RIM Rab3-binding domain.Constitutively Monomeric Mutant of Munc13 Rescues
Loss of Priming in RIM-Deficient Neurons
The unexpected ability of the isolated RIM Zn2+ finger to activate
priming in RIM-deficient neurons indicates that RIMs prime
vesicle fusion by an autonomous effect of their Zn2+ finger and
suggests that the Zn2+ finger promotes priming by converting
an autoinhibitory Munc13 C2A domain homodimer into an active
Zn2+ finger/C2A domain heterodimer (Figure 6A). However, other
mechanisms of action for the Zn2+ finger are also possible; for
example, the RIM Zn2+ finger could bind to other, as yet uniden-
tified, targets, or binding of the RIM Zn2+ finger to Munc13 may
induce other downstream effects in addition to disrupting the
C2A domain homodimer.
The hypothesis that the RIM Zn2+ finger domain promotes
priming by disrupting Munc13 homodimers predicts that consti-
tutively monomeric Munc13 should be able to rescue the impair-
ment of priming observed in RIM-deficient neurons, which would
not be the case if the RIM Zn2+ finger bound to other targets or
produced other effects onMunc13. Thus, to test this hypothesis,
we expressed in RIM-deficient neurons wild-type ubMunc13-2
(as a control) and mutant ubMunc13-2 that is constitutively
monomeric (to examine the role of Munc13 monomerization by
the RIM Zn2+ finger). We chose a previously characterized
Munc13 point mutation (K32E) that does not interfere with RIM
binding by Munc13 but converts the Munc13 C2A domain into
a constitutive monomer (Lu et al., 2006, Figure 6A).
Expression of wild-type Munc13 had no significant effect on
the decreased minifrequency in cDKO neurons, but mutant,
constitutively monomeric Munc13 rescued 50% of the impair-
ment (Figure 6B). Strikingly, when we measured the RRP using
hypertonic sucrose, wild-type Munc13 overexpression again
had no significant rescue effect, but the constitutively mono-
meric Munc13 mutant nearly completely rescued the decrease
in the RRP in RIM-deficient neurons (Figure 6C and Figure S6A).
Overexpression of wild-type or mutant ubMunc13-2 in wild-type
neurons did not significantly alter the minifrequency and RRP size
(Figures 6B and 6C, right). Immunostaining with pan-Munc13
or ubMunc13-2 antibodies confirmed that both wild-type and
mutant, constitutively monomeric Munc13 were similarly ex-
pressed and partially localized to synapsin-positive presynaptic
terminals (Figure 6D). Immunoblotting and quantitative RT-PCR
further showed that there were no significant differences in
expression levels of the two Munc13 constructs (Figures S6B
and S6C). Together, these data show that the differential rescue
effects of wild-type and mutant Munc13 are a function of
Munc13 monomerization and are not due to differences in
expression levels and/or synaptic targeting. Thus, a mutation
that renders Munc13 constitutively monomeric serves as a
second-site suppressor of the RIM deletion phenotype, bypass-
ing the requirement for RIM in vesicle priming.
Does the rescue with wild-type or constitutively monomeric
mutant Munc13 restore physiological synaptic responses and
does it alter the Ca2+ sensitivity of release? To address this ques-
tion,wemeasuredaction-potential-evoked IPSCs as a function of
the extracellular Ca2+ concentration (Figure 6E and Figures S6D–
S6F). Again, expression of wild-type Munc13 had no detectable
effect on the massive decrease in IPSC amplitudes produced by
theRIMdeletion,whereasexpressionof constitutivelymonomericNeuron 69, 317–331, January 27, 2011 ª2011 Elsevier Inc. 323
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Figure 6. Constitutively Monomeric Mutant ubMunc13-2 Bypasses the Loss of Priming in RIM-Deficient Neurons
(A) Diagram of wild-type and mutant ubMunc13-2 rescue proteins expressed in cDKO neurons. Key domains of Munc13 (C1 and C2 domains and the MUN
domain. V is an abbreviation for mVenus-tag) and their interactions are indicated (DAG is an abbreviation for diacylglycerol). Cre-recombinase and Munc13s
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Neuron
Mechanism of vesicle priming by RIMmutant Munc13 rescued approximately half of the decrease in
synaptic responses induced by deletion of RIMs (Figure 6E),
similar to the rescue of the mIPSC frequency (Figure 6B). When
we analyzed the Ca2+ dependence of the IPSCs by fitting the
data to a Hill function, mutant or wild-type Munc13 had no effect
on the decreased apparent Ca2+ affinity of release induced by
the RIMdeletion (Figures 6E andFigure S6D). This result supports
the notion that the impairedCa2+ channel localization in RIM-defi-
cient synapses is not restored by overexpression of constitutively
monomeric or wild-typeMunc13 because the Ca2+ channel local-
ization depends on a direct interaction of RIM with Ca2+ channels
(Kaeser et al., 2011), which is independent of Munc13.
So far, our data suggest that RIMs promote vesicle priming by
disrupting the Munc13 C2A-homodimer. However, it is possible
that the Munc13 C2A domain performs an additional function
that is activatedwhen it is released from the homodimer, i.e., that
it is not the homodimer per se that is inhibitory but that the homo-
dimer occludes a critical additional activity of the C2A domain.
To test this possibility, we investigated a truncation mutant of
Munc13 that lacks the C2A domain and thus cannot mediate
any C2A-domain-dependent activity, including homodimeriza-
tion (referred to as ubMunc13-2DC2A; Figure 7A). Experiments
in transfected HEK293 cells confirmed that as expected, this
N-terminally truncated Munc13 mutant does not interact with
RIM1a nor does it form homodimers (Figures 7B and 7C and Fig-
ure S7A). This Munc13 mutant also largely rescued the minifre-
quency (Figure 7D) and entirely reversed the loss of vesicle
priming in RIM-deficient neurons (Figure 7E). Thus, monomeric
Munc13 does not require its N-terminal C2A domain to rescue
the priming impairment in RIM-deficient neurons, and the C2A
domain thus probably acts to inhibit the Munc13 priming func-
tion by homodimerization, which is reversed by RIM.Wild-Type and Monomeric Munc13 Rescue
Priming in Munc13-Deficient Synapses
In RIM-deficient cDKO neurons, Munc13 levels are reduced by
67% (Figure 1E). Our data show, however, that RIMs do not
mediate priming by simply stabilizing Munc13 levels since
wild-type Munc13 cannot rescue the RIM deficiency phenotype.
Instead, we find that RIMs act by activatingMunc13 and suggest
furthermore that the major function of the Munc13 C2A domain is
to autoinhibit Munc13 function by homodimerization in the
absence of RIM, with the autoinhibition being reversed when
RIMs disrupt the homodimerization. However, it is possible
that the Munc13 C2A domain performs additional RIM-indepen-were expressed from separate lentiviruses by consecutive infection (cre and cont
Munc13 C2A domain (Munc13
K32E) renders Munc13 constitutively monomeric (L
(B) Sample traces (left) and summary graph (right) of the frequency of spontaneous
wild-type or mutant Munc13 expression (top 4 traces and left panels) or in wild-t
(C) Sample traces (left) and summary graphs (right) of RRP size in control and
expression.
(D) Confocal sections of cDKO neurons with or without rescue stained for all Munc
antibodies. Note that wild-type and mutant ubMunc13-2 rescue proteins exhibit
(E) Expression of K32E mutant but not wild-type ubMunc13-2 partially rescues th
but does not rescue their impaired Ca2+ responsiveness.
Data shown are means ± SEMs (numbers in bars indicated numbers of cells an
(*p < 0.05; **p < 0.01; ***p < 0.001). For additional analyses and numerical data,dent functions in release that would be mediated in our rescue
experiments by the continued presence of wild-type Munc13 in
the RIM-deficient neurons. To test this possibility, we character-
ized the ability of wild-type and mutant ubMunc13-2 to rescue
the reduced priming observed in neurons with strong reductions
in total Munc13 levels. If our conclusions were correct, both wild-
type and monomeric ubMunc13-2 should rescue priming in
these neurons because RIM is present to monomerize wild-
type Munc13 and because mutant ubMunc13-2K32E lacking
homodimerization should be constitutively active. Furthermore,
monomeric mutant ubMunc13-2DC2A unable to bind RIMs
should also rescue priming, in line with previous reports suggest-
ing that the MUN domain of Munc13 is the minimal domain
required for Munc13 mediated vesicle priming (Basu et al.,
2005; Madison et al., 2005; Stevens et al., 2005).
To suppress Munc13 levels, we screened shRNAs against
Munc13-1. We identified one shRNA (KD91) that strongly dimin-
ished Munc13-1 mRNA and protein levels (Figures 8A and 8B;
80% knockdown [KD] efficiency). We then cultured neurons
from constitutive Munc13-2 KO mice (Varoqueaux et al., 2002)
and infected them either with lentiviruses expressing the
Munc13-1KDshRNAorwithemptycontrol lentiviruses inaddition
to lentiviruses expressing rescue proteins (Figures S8A–S8C).
Munc13-deficient neurons exhibited a significant decrease in
minifrequency and RRP size (Figures 8C–8F). Both parameters
were rescued by re-expression of wild-type ubMunc13-2, of
mutant ubMunc13-2K32E containing the C2A domain point muta-
tion, or of mutant ubMunc13-2DC2A in which the C2A domain is
deleted (Figures 8C–8F, and Figures S8D–S8E). These data
rule out nonspecific effects during the rescue of priming in
RIM-deficient neurons by the various Munc13 mutants, and—
more importantly—confirm that RIMs serve as a molecular
switch that disrupts Munc13 homodimers in synaptic vesicle
priming.DISCUSSION
In the present study, we explore the mechanism of action of RIM
andMunc13 proteins in synaptic vesicle priming. Wemake three
principal observations that are unexpected in view of current
ideas about RIM and Munc13 function and vesicle priming,
namely (1) that the RIM Zn2+ finger domain activates priming
autonomously as a switch not by mediating the coassembly of
multiple proteins into a protein complex at the active zone, (2)
that the RIM Zn2+ finger switches on priming by activatingrol viruses at DIV3, Munc13 viruses at DIV5). Note that the K32E mutation of the
u et al., 2006).
mIPSCsmonitored in control and RIM-deficient cDKO neurons with or without
ype neurons with Munc13 expression (bottom two traces and right panels).
cDKO neurons with or without rescue or in wild-type neurons with Munc13
13 isoforms (top) or for ubMunc13-2 (bottom) and counterstained with synapsin
similar levels and localizations.
e amplitude of action-potential evoked IPSCs in RIM-deficient cDKO neurons
d cultures analyzed). Statistical significance was assessed by 1-way ANOVA
see Figure S6 and Table S6.
Neuron 69, 317–331, January 27, 2011 ª2011 Elsevier Inc. 325
ubMunc13-2ΔC2A C2B Mun C2C mVC1 V
M
13
-2
M
13
-2
ΔC
2A
M
13
-2
M
13
-2
ΔC
2A
RIM1α +
glutar-
aldehyde:
0.008%0%
202
202RIM1α
monomer
ubMunc13-2
monomer
ubMunc13-2ΔC2A
monomer
complexed
ubMunc13-2
complexed
RIM1α
A
B C
C2A C2B Mun C2C mVubMunc13-2 C1 V
homodimer
α-RIM
1 
nA
5 s
Sucrose
Control
 RIM cDKO
cDKO + ubMunc13-2ΔC2A
D
E
Ch
ar
ge
 tr
an
sf
er
(nC
) 0
-10
 
s
0
4
8
12
0
1
2
Co
ntr
ol
cD
KO
cD
KO
 + 
M1
3-2
ΔC
2A
Co
ntr
ol
cD
KO
cD
KO
 + 
M1
3-2
ΔC
2A
*
*
*
1
3
/
3
1
6
/
3
1
6
/
3
1
3
/
3
1
6
/
3
1
6
/
3
*
*
*
0
1
2
m
IP
SC
 fr
eq
ue
nc
y 
(H
z)
0
20
40
m
IP
SC
 a
m
pl
itu
de
 (p
A)
1
2
/
3
1
6
/
3
1
3
/
3
1
2
/
3
1
6
/
3
1
3
/
3
Control
cDKO + ubMunc13-2ΔC2A
50
 p
A
1 s
 RIM cDKO
Co
ntr
ol
cD
KO
cD
KO
 + 
M1
3-2
ΔC
2A
Co
ntr
ol
cD
KO
cD
KO
 + 
M1
3-2
ΔC
2A
*
*
*
Ch
ar
ge
 tr
an
sf
er
(nC
) 1
5-3
0 s
GFP
antib.
RIM
antib.
N
N
N
N
RIM1α RIM1α
M
13
-2
 +
M
13
-2
ΔC
2A
 
+
- PMA
- PMA
+ PMA
+ PMA
SNAREs
Ca2+
DAG
Figure 7. The ubMunc13-2 C2A Domain
Is Dispensable for Rescuing the RRP in
RIM-Deficient Neurons
(A), Diagram of ubMunc13-2 rescue proteins ex-
pressed in cDKO neurons via an IRES sequence
from the same mRNA as cre-recombinase. Key
interactions of various domains are indicated.
(B) Colocalization of full-length RIMs andMunc13s
in HEK293 cells depends on the Munc13 C2A
domain. RIM1a and wild-type or DC2A mutant
ubMunc13-2 were transfected into HEK293 cells
and their colocalization was studied before
(PMA) or after phorbol ester-induced transloca-
tion (+PMA) of Munc13 to the plasma membrane.
Note that without Munc13 binding (i.e., with
DC2A mutant ubMunc13-2), RIM is largely local-
ized to nuclei in nonneuronal cells, whereas in
the presence of wild-type ubMunc13-2, it is either
cytosolic (PMA) or on the plasma membrane
(+PMA) (N is an abbreviation for nucleus; the scale
bar represents 5 mm).
(C) Crosslinking of wild-type or DC2A mutant ub-
Munc13-2 with RIM1a. HEK293 cells expressing
the indicated proteins were treated in control
solution or solution containing 0.008% glutaralde-
hyde, and proteins were analyzed by SDS-PAGE
and immunoblotting with antibodies against the
mVenus tag of Munc13 and the central domains
of RIM (R809).
(D) Sample traces (left) and summary graph (right)
of miniature mIPSCs monitored in control neurons
and cDKO neurons with or without ubMunc13DC2A
expression.
(E) Sample traces (left) and summary graphs (right)
of RRP size in control neurons and cDKO neurons
with or without ubMunc13DC2A rescue. Initial (left)
and steady-state RRP sizes (right) are indicated.
Data shown are means ± SEMs (numbers in bars
indicated numbers of cells and cultures analyzed).
Statistical significance was assessed by one-way
ANOVA (***p < 0.001). For additional data, see
Figure S7.
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Mechanism of vesicle priming by RIMMunc13 and does so by disrupting constitutive Munc13 homo-
dimers produced by their C2A domain, and (3) that C2A
domain-mediated homodimerization of Munc13 inhibits its
priming function in the absence of RIM but is disinhibited by
the RIM Zn2+ finger (Figure 8G). Note that we refer to priming
in a broad sense, defined operationally as the process that
renders vesicles sensitive to stimulation by hypertonic sucrose,
and do not attempt to differentiate between stages of vesicle
docking and priming. The distinction between docking and prim-
ing is classically made by electron microscopy, but the case of326 Neuron 69, 317–331, January 27, 2011 ª2011 Elsevier Inc.Munc13 illustrates how tenuous this
distinction can be. Although in traditional
electron microscopy experiments no
docking defect in Munc13-deficient
synapses was observed (Augustin et al.,
1999a; Varoqueaux et al., 2002), a recent
study using high-pressure freezing
reached the opposite conclusion (Siksouet al., 2009). It is unclear which of the two electron microscopy
approaches renders a ‘‘true’’ picture; thus, we make no attempt
to tease apart physical vesicle attachment (docking) and conver-
sion of attached into release-ready vesicles (priming), but use the
term ‘‘priming’’ in a generic sense as defined above.
RIMs Act in Priming as Molecular Switches Not as
Scaffolds Mediating Coassembly of Multiple Proteins
Classical scaffolding molecules often act by producing the co-
localization of multiple downstream effectors (Mishra et al.,
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Figure 8. Wild-Type and Constitutively Monomeric
Mutant ubMunc13-2 Rescue Priming in Munc13-
Deficient Neurons
(A) Immunoblotting for Munc13-1 and control proteins in
neurons from Munc13-2 KO mice infected with control
lentiviruses or with the Munc13-1 KD virus. Neurons
were consecutively infected with the Munc13 rescue or
control lentiviruses at DIV3 and with the Munc13-1 KD or
control lentiviruses at DIV5.
(B) Quantitative real-time RT-PCR measurements of the
mRNA levels of Munc13-1 in control and Munc13-1 KD
neurons.
(C and D) Sample traces (left) and summary graph (right) of
the spontaneous mIPSC frequency monitored in control
neurons and M13 KD neurons either with or without
ubMunc13 or ubMunc13K32E rescue (C) or ubMunc13DC2A
rescue (D). Data of mIPSC amplitudes are shown in
Figure S7.
(E) Sample traces (left) and summary graphs (right) of RRP
size in control neurons and Munc13 KD neurons with or
without ubMunc13 rescue. Initial (left) and steady-state
RRP sizes (right) are indicated.
(F) Sample traces (left) and summary graphs (right) of RRP
size in control neurons, and Munc13 KD neurons with or
without ubMunc13DC2A rescue. Initial (left) and steady-
state RRP sizes (right) are indicated.
(G) Model of the RIM priming switch. We propose that RIM
activates priming by disrupting autoinhibitory Munc13 C2A
domain homodimers. The inactive Munc13 homodimer is
physiologically activated by the RIM Zn2+ finger domain
that converts the homodimer into a RIM/Munc13 hetero-
dimer. This activation can be bypassed with constitutively
monomeric mutant Munc13K32E or Munc13 DC2A, but not
with wild-type Munc13, in RIM-deficient neurons.
Data shown are means ± SEMs (numbers in bars indicated
numbers of cells and cultures analyzed). Statistical
significance was assessed by 1-way ANOVA (*p < 0.05;
**p < 0.01; ***p < 0.001). For additional data, see Figure S8.
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Mechanism of vesicle priming by RIM2007; Pawson and Scott, 2010). RIMs were presumed to act as
scaffolds in this sense because of their domain structure
(Schoch et al., 2002). However, we find that surprisingly, the
RIM Zn2+ finger autonomously promotes vesicle priming by
directly activating Munc13. With this observation, we revise our
previous conclusions based on peptide injections into the calyx
of Held synapse (Dulubova et al., 2005), which seemed to
suggest that uncoupling the domains of RIM suppresses their
function. The present genetic approach is a more definitive
approach than peptide injections, as it does not depend on un-
physiologically high protein levels to achieve a dominant-nega-
tive effect but utilizes rescue of a loss-of-function state as an
assay. It seems likely that the high peptide concentrations
used previously produce unintended effects unrelated to the
normal function of RIM, illustrating the general difficulty of inter-
preting experiments in which a protein fragment is introduced
into a wild-type synapse at high concentrations (Su¨dhof, 2004).
If RIM proteins are not scaffolds for the coassembly of proteins
into complexes, why do they have a multidomain structure? One
possibility is that the autonomous function of the RIM Zn2+ finger
domain in priming is subject to intramolecular regulation, which
could be involved in the role of RIM in long-term presynaptic
plasticity (Castillo et al., 2002; Chevaleyre et al., 2007; Fourcau-
dot et al., 2008; Kaeser et al., 2008). Another possibility is that
assembly of the autonomous functions of different RIM domains
into a single protein ensures the right relative activity of these
domains, i.e., a constant ratio of their activities. A third possibility
is that this arrangement may be economical in terms of orga-
nizing the expression and localization of somany activities medi-
ated by different domains.
RIMs Switch on Priming by Disrupting
Munc13 Homodimers
Crystal structures revealed that the Munc13 C2A domain forms
a tight homodimer with nanomolar affinity; this dimer is disrupted
by binding of the RIM Zn2+ finger, resulting in Zn2+ finger/C2A
domain heterodimers (Dulubova et al., 2005; Lu et al., 2006).
Our results suggest that Munc13 homodimerized by its C2A
domain is inactive in priming but activated by the RIM Zn2+ finger
binding that disrupts the homodimer. The strongest evidence for
this conclusion comes from the suppression of the priming
phenotype in RIM-deficient synapses by mutant, constitutively
monomeric Munc13, but not by wild-type Munc13 (Figures 6
and 7). Note that the constitutively monomeric Munc13 mutants
rescued only the priming deficit of RIM-deficient neurons not
their Ca2+-triggering phenotype, which manifested in a 50%
rescue of synaptic strength in the RIM-deficient neurons by the
mutant Munc13 (Figure 6E). Furthermore, whereas only mutant,
constitutively monomeric Munc13 but not wild-type Munc13
rescued priming in RIM-deficient neurons, both mutant
Munc13 and wild-typeMunc13 rescued priming in Munc13-defi-
cient neurons (Figure 8). An alternative hypothesis to the model
proposed here is that an as yet unidentified protein binds to
the Munc13 C2A domain and inhibits Munc13 function and that
this protein is displaced by the RIM Zn2+ finger. However, this
hypothesis would require that the putative Munc13-binding
protein has nanomolar affinity for Munc13 (since it has be
stronger than Munc13 homodimerization) that it is nevertheless328 Neuron 69, 317–331, January 27, 2011 ª2011 Elsevier Inc.displaced from Munc13 by RIM. In addition, the putative
Munc13-binding protein would be required to bind to the site of
Munc13 homodimerization, effectively suppressing it because
theC2Adomainwouldalwaysbeeitherbound toRIMor to theother
protein. Viewed together, these improbable requirements render
the alternative hypothesis highly unlikely and nonparsimonious.
TheMunc13 C2A Domain Functions as an Autoinhibitory
Module that Blocks Priming by Homodimerization
The autoinhibitory function of the Munc13 C2A domain is
surprising since no other C2 domain has been associated with
a comparable function. Of four principal synaptic Munc13 iso-
forms (Munc13-1, ubMunc13-2, bMunc13-2, and Munc13-3),
only the first two contain a C2A domain (Brose et al., 1995;
Augustin et al., 1999b; Koch et al., 2000), raising the question of
how the other two Munc13 isoforms (which are less abundant)
are regulated and whether they are possibly controlled by
a different RIM-dependent mechanism. It seems likely that
Munc13 acts on SNARE proteins in priming (Basu et al., 2005;
Madison et al., 2005; Stevens et al., 2005; Guan et al., 2008),
but the mechanisms of Munc13 function in priming, and of the
inactivation of Munc13 function by homodimerization, remain
unclear. One possibility is that homodimericMunc13 is inherently
unstable and becomes degraded in RIM-deficient neurons,
thereby accounting for the priming phenotype and the reduced
Munc13 levels in RIM-deficient neurons (Figure 1; Schoch et al.,
2002). However, overexpression of wild-type Munc13 did not
rescue theprimingphenotype inRIM-deficient neurons, suggest-
ing that simply increasingMunc13 levels is not sufficient to rescue
priming in RIM-deficient synapses. Another possibility is that
homodimeric Munc13 is not correctly targeted to synapses and
becomes degraded if it is not in the correct location (Andrews-
Zwilling et al., 2006; Kaeser et al., 2009). Although possible, this
hypothesis appears rather unlikely given the rescue of the RIM-
and Munc13-deficiency phenotypes by N-terminally truncated
Munc13 (Figures 7 and 8), which suggests that Munc13 is trans-
ported to synapses without RIM proteins and without binding to
RIM proteins. Independent of which explanation will turn out to
be correct, the mechanism of Munc13 activation we identify
here is opposite to what is classically observed for signal trans-
duction events; dimerization is usually activating, whereas in
our case it is inhibitory, suggesting a more diverse range of
biological activation mechanisms than previously envisioned.
Outlook
The current study identifies a molecular mechanism involved in
vesicle priming by the active zone but raises new questions. At
a basic level, how is an active zone generated—what protein
nucleates its assembly? The fact that the RIM Zn2+ finger alone
is active suggests that it acts downstream of Munc13 targeting
to active zones and cannot physically tether Munc13 to them;
similarly, Munc13 is not essential for targeting other proteins to
active zones and thus also not involved in their recruitment to
active zones. Clearly, despite its central function, RIM alone
does not organize the active zone, an activity that may be carried
out by an overlapping set of several proteins instead of a single
master regulator. Another important question is how RIM
proteins contribute to long-term synaptic plasticity—is this
Neuron
Mechanism of vesicle priming by RIMmediated by a coordination of their various functions or by one
particular aspect? With the present results, we now know of
two switches at the active zone that involve RIM and regulate
synaptic neurotransmitter release: the GTP-dependent interac-
tion of Rab3 with RIMs, and the Zn2+ finger mediated RIM-
dependent monomerization of Munc13. Given the central roles
of RIM and Rab3 in all known forms of long-term presynaptic
plasticity (e.g., Castillo et al., 1997, 2002; Chevaleyre et al.,
2007; Fourcaudot et al., 2008, Kaeser et al., 2008), a plausible
hypothesis is that these switches could be regulated by synaptic
activity and thus mediate such plasticity, an exciting hypothesis
that would account for the enormous effects of presynaptic
plasticity on neurotransmitter release.
EXPERIMENTAL PROCEDURES
Primary Hippocampal Cultures, Lentiviral Infections,
and Rescue Constructs
High-density hippocampal cultures were prepared from newborn mice and in-
fected with lentiviruses as described (Kaeser et al., 2009). The RIM1 rescue
constructs were generated from rat RIM1a (Wang et al., 1997) or RIM1b
(Kaeser et al., 2008) and are described in the Supplemental Experimental
Procedures. The GFP-tagged rat ubMunc13-2 lentivirus was previously pub-
lished (Rosenmund et al., 2002). In contrast to the RIM rescue constructs
that were expressed bicistronically with an internal ribosome entry site (IRES
sequence [Kaeser et al., 2009, 2011]), the Munc13-overexpression experi-
ments were performed by superinfection of cre-infected cultures with
Munc13-expressing lentiviruses.
Electrophysiology
Whole-cell patch-clamp recordings were performed in cultured hippocampal
neurons at DIV13-15 as described (Maximov et al., 2007, Kaeser et al.,
2009, Kaeser et al., 2008, Maximov et al., 2009). The extracellular solution con-
tained (in mM) 140 NaCl, 4 KCl, 2 CaCl2, 2 MgCl2, 10 HEPES-NaOH (pH 7.3),
and 10 glucose, with 315 mOsm. Glass pipettes (3–5 MU) were filled with an
internal solution containing (in mM) 145 CsCl, 5 NaCl, 10 HEPES-CsOH
(pH 7.3), 10 EGTA, 4 MgATP, and 0.3 Na2GTP, with 305 mOsm. mEPSCs
and mIPSCs were recorded in the presence of 1 mM tetrodotoxin (TTX) plus
either 50 mM picrotoxin and 50 mM APV (mEPSCs) or 10 mM CNQX and
50 mM D-APV (mIPSCs), respectively. For measurement of RRP, 0.5 M hyper-
tonic sucrose was perfused with a picospritzer in the presence of 1 mM TTX
(except for the experiments in Figure 2B, where TTX was omitted), 10 mM
CNQX, and 50 mM D-APV. Ca2+ titration experiments were performed as
described (Kaeser et al., 2011). RRP rescue efficacy was calculated according
to following equation:% = (mean rescue charge transfermean cDKO charge
transfer)/(mean control charge transfer  mean cDKO charge transfer) * 100,
where the mean charge transfer is the average of sucrose-induced charges
of neurons recorded in the same batch of culture. Data were acquired with
a multiclamp 700B amplifier with pClamp9, sampled at 10 Hz, and filtered at
1 Hz. In all experiments, the experimenter was blind to the genotype.
Protein Quantitations in Neuronal Cultures
Neurons were harvested in a detergent free buffer, homogenized with a glass-
teflonhomogenizer, andspunat 256,0003g for 30min, and thepelletwasused
for protein quantitations. Protein contents were adjusted by use of a bicincho-
ninic (BCA) protein assay kit (Pierce Biotechnology). Twenty micrograms of
protein was loaded per lane on standard SDS/Page gels for western blotting,
125iodine-labeled secondary antibodies were used for detection as previously
described (Kaeser et al., 2008), and valosin-containing protein (VCP), GDP
dissociation inhibitor (GDI), and b-actin were used as internal standards.
Protein Interaction Assays
Munc13/RIM colocalization experiments in transfected HEK293T cells were
performed as described (Andrews-Zwilling et al., 2006). Crosslinking experi-
ments were performed in transfected HEK293T cells and were induced with0.008% glutaraldehyde after membrane recruitment of Munc13 with phorbol
esters. Detailed experimental protocols are in the Supplemental Information.
Immunofluorescence Staining of Cultured Neurons
Cultured neurons were fixed in 4% paraformaldehyde/phosphate-buffered
saline, permeabilized in 0.1% Triton X-100/3% bovine serum albumin/phos-
phate-buffered saline, and incubated overnight with anti-Munc13 rabbit
polyclonal antibodies (antibody 41, 1:2000) or anti-ubMunc13-2 rabbit poly-
clonal antibodies (antibody 52, 1:2000), and anti-synapsin mouse monoclonal
antibodies (Synaptic Systems, 1:1000). Alexa-Fluor 546 anti-mouse and
Alexa-Fluor 633 anti-rabbit secondary antibodies were used for detection.
Images were acquired with a Leica TCS2 confocal microscope with identical
settings applied to all samples in an experiment. Single confocal sections
were recorded at 1 airy unit pinhole.
Munc13-1 Knockdown
The Munc13-1 KD sequence (KD91, GCCTGAGATCTTCGAGCTTAT) was ex-
pressed from an H1 promotor sequence in a lentiviral vector and was followed
by a ubiquitin promoter-driven mCherry. Munc13-deficient neurons were
generated by Munc13-1 knockdown in Munc13-2 constitutive knockout
neurons (Varoqueaux et al., 2002). Munc13-2 knockout neurons expressing
mCherry but not Munc13-1 KD shRNA were used as control neurons.
Miscellaneous
SDS/PAGE gels and immunoblotting were done according to standard
methods described in the Supplemental Information (Kaeser et al., 2009;
Kaeser et al., 2008). In all experiments, the experimenter was blind to the
condition and/or genotype. All animal experiments were performed according
to institutional guidelines. All data are shown as means ± standard error of the
mean (SEM). Statistical significance was determined by one-way analysis of
variance (ANOVA) (electrophysiological recordings) or Student’s t test (all other
experiments). All numerical and statistical values and the tests used can be
found in the Tables S1–S8.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
eight figures and eight tables and can be found with this article online at
doi:10.1016/j.neuron.2011.01.005.
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